MediWound Ltd. is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for severe burns and chronic wounds. With a focus on advanced wound care, they aim to improve healing outcomes and patient quality of life. Their products are backed by extensive research and clinical trials, positioning them as a leader in the field.
